BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/11/2015 4:38:00 PM | Browse: 1275 | Download: 1788
 |
Received |
|
2014-06-19 09:19 |
|
Peer-Review Started |
|
2014-06-19 19:12 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2014-07-28 16:27 |
|
Revised |
|
2014-09-03 14:58 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2014-11-17 12:03 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2014-11-19 09:08 |
|
Articles in Press |
|
2014-11-19 09:40 |
|
Edit the Manuscript by Language Editor |
|
2014-12-02 21:56 |
|
Typeset the Manuscript |
|
2015-01-31 16:29 |
|
Publish the Manuscript Online |
|
2015-02-11 16:38 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Biochemistry & Molecular Biology |
| Manuscript Type |
Basic Study |
| Article Title |
Mechanism of action of gypenosides on type 2 diabetes and non-alcoholic fatty liver disease in rats
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Qin He, Jin-Ke Li, Fang Li, Ru-Gui Li, Guo-Qing Zhan, Gang Li, Wei-Xing Du and Hua-Bing Tan |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Bureau of Public Health of Hubei Province |
|
|
| Corresponding Author |
Hua-Bing Tan, Professor, Department of Infectious Diseases and Lab of Liver Disease, Renmin Hospital, Hubei University of Medicine, 39 Chaoyangzhong Road, Shiyan 442000, Hubei Province, China. tanhb_2013@163.com
|
| Key Words |
Gypenosides; Type 2 diabetes mellitus; Non-alcoholic fatty liver; PPARγ; Cytochrome P4501A1 |
| Core Tip |
Gypenosides (GPs) are one of the most phar-macologically active components in G. pentaphyllum. Intervention with GPs significantly decreased the levels of aspartate aminotransferase, alanine aminotransferase, blood glucose, insulin, triglycerides and total cholesterol in type 2 diabetes mellitus and non-alcoholic fatty liver disease (T2DM-NAFLD) model rats, down-regulated the expression of TNF-α, NF-κB, rabbit anti-proliferator activated receptory (PPARγ) and rabbit anti-cytochrome P4501A1 (CYP1A1) mRNA, decreased the infiltration of liver fats and reversed the histopathological changes in a dose-dependent manner. These findings suggest that GPs have a protective effect against T2DM-NAFLD by down-regulating the expression of TNF-α and NF-κB proteins, and PPARγ and CYP4501A1 mRNAs.
|
| Publish Date |
2015-02-11 16:38 |
| Citation |
He Q, Li JK, Li F, Li RG, Zhan GQ, Li G, Du WX, Tan HB. Mechanism of action of gypenosides on type 2 diabetes and non-alcoholic fatty liver disease in rats. World J Gastroenterol 2015; 21(7): 2058-2066 |
| URL |
http://www.wjgnet.com/1007-9327/full/v21/i7/2058.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v21.i7.2058 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
